1 October 2026

Cancer PBAC PBS Pharmaceuticals

Goserelin wins six-month PBS reprieve

24 September 2026

Diabetes PBAC PBS RACGP

RACGP pushes to keep streamlined authority GLP-1 PBS listing

7 September 2026

PBAC PBS Pharmaceuticals Vaccination

Obesity GLP-1 RA to go back before PBAC

1 September 2026

PBS Pharmaceuticals Public Health

PBS drops hep B accreditation

31 August 2026

Cancer Immunotherapy PBS Pharmaceuticals

PBS widens pembrolizumab access

24 August 2026

PBAC PBS Pharmaceuticals

PBAC backs new women’s health options for PBS

24 August 2026

Diabetes PBS TGA

NMSC: common, deadly, preventable

18 August 2026

PBAC PBS Pharmaceuticals

PBAC nod for unrestricted triptorelin access

13 August 2026

Diabetes PBS Pharmaceuticals

Butler vows to get GLP-1s on PBS, ‘one way or the other’

13 August 2026

Biosimilars PBS Pharmaceuticals

GBMA targets medicine shortages

6 August 2026

Biologics Gastroenterology IBD PBS Pharmaceuticals

IBD patients caught in Australia’s medicines access gap

17 July 2026

federal government PBAC PBS Pharmaceuticals

PBS reprieve for MS blockbusters

16 July 2026

Breast cancer Clinical PBS

AstraZeneca announces new access program for cancer implant

7 July 2026

PBS Pharmaceuticals Rheumatology

Another myasthenia gravis add-on given PBS listing

3 July 2026

Addiction PBS Pharmaceuticals

‘Commercial decision’ to withdraw opioid addiction treatment

2 July 2026

Allergies PBS

Intranasal adrenaline added to PBS